Intimation for Clousure of Trading Window for Half Year ended 30th September, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shelter Pharma Ltd has informed BSE that its trading window will be closed from 1st October 2025 until 48 hours after the declaration of unaudited financial results for the half-year ended 30th September 2025. This applies to all directors, key managerial personnel, designated employees, and their immediate relatives, in compliance with SEBI's Prohibition of Insider Trading Regulations. The date of the board meeting to approve these half-yearly results will be announced separately. The intimation is signed by Managing Director Mustaqim Nisar Ahmed Sabugar on 29th September 2025.
This is a routine regulatory compliance intimation with no direct impact on the stock price or shareholders. It signals that the company's half-yearly results are approaching and that insiders are restricted from trading in the stock during this period.